Valiant Laboratories Profile
Key Indicators
- Authorised Capital ₹ 45.00 Cr
- Paid Up Capital ₹ 43.45 Cr
- Company Age 3 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 61.40 Cr
- Satisfied Charges ₹ 52.00 Cr
- Revenue Growth 61.39%
- Profit Growth 27.66%
- Ebitda 16.37%
- Net Worth 40.62%
- Total Assets 21.99%
About Valiant Laboratories
Valiant Laboratories Limited (VLL) is a Public Limited Indian Non-Government Company incorporated in India on 16 August 2021 (Three years and five months 16 days old ). Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 45.00 Cr and a paid-up capital of Rs 43.45 Cr.
The company currently has active open charges totaling ₹61.40 Cr. The company has closed loans amounting to ₹52.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Valiant Laboratories Limited India are Paresh Shah as CFO and Prajakta Patil as Company Secretary. Velji Gogri, Mulesh Savla, Shantilal Vora, and Four other members serve as directors at the Company.
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media-
Corporate Identity Details
- CIN/LLPIN
L24299MH2021PLC365904
- Company No.
365904
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
16 Aug 2021
- Date of AGM
13 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Listed
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Valiant Laboratories?
Executive Team (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Santosh Vora  | Managing Director | 16-Aug-2021 | Current |
| Paresh Shah | CFO | 06-Feb-2022 | Current |
| Prajakta Patil | Company Secretary | 11-Jun-2024 | Current |
Board Members (6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Velji Gogri | Director | 06-Feb-2022 | Current |
| Mulesh Savla | Additional Director | 11-Jun-2024 | Current |
| Shantilal Vora | Director | 16-Aug-2021 | Current |
| Paresh Shah | Director | 16-Aug-2021 | Current |
| Sandeep Gupta | Director | 23-Feb-2023 | Current |
| Sonal Vira | Director | 16-Feb-2022 | Current |
Financial Performance of Valiant Laboratories.
Valiant Laboratories Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 61.39% increase. The company also saw a substantial improvement in profitability, with a 27.66% increase in profit. The company's net worth Soared by an impressive increase of 40.62%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Valiant Laboratories?
In 2023, Valiant Laboratories had a promoter holding of 72.51% and a public holding of 27.49%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Valiant Organics LimitedMulesh Savla, Santosh Vora and 1 more are mutual person
Aarti Surfactants LimitedMulesh Savla is a mutual person
Shah And Savla LlpMulesh Savla is a mutual person
- Shantilal Vora & Sons Llp
Shantilal Vora and Santosh Vora are mutual person
- Valiant Advanced Sciences Private Limited
Santosh Vora, Paresh Shah and 1 more are mutual person
- Empeef Chemicals Pvt Ltd
Paresh Shah is a mutual person
Charges (Loans)
₹61.40 Cr
₹52.00 Cr
Charges Breakdown by Lending Institutions
- Others : 52.00 Cr
- The Hongkong And Shanghai Banking Corporation Limited : 9.40 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 08 Jun 2024 | The Hongkong And Shanghai Banking Corporation Limited | ₹4.40 Cr | Open |
| 28 Feb 2024 | The Hongkong And Shanghai Banking Corporation Limited | ₹5.00 Cr | Open |
| 23 Sep 2022 | Others | ₹52.00 Cr | Open |
| 14 Oct 2022 | Others | ₹52.00 Cr | Satisfied |
How Many Employees Work at Valiant Laboratories?
Valiant Laboratories has a workforce of 84 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Valiant Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Valiant Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
